OR WAIT null SECS
LGC (Cambridge, UK) has acquired the Bioanalytical Sciences division of Quotient (Cambridge, UK).
LGC (Cambridge, UK) has acquired the Bioanalytical Sciences division of Quotient (Cambridge, UK). The acquisition follows the sale of HFL Sport Science (Cambridge, UK) by Quotient to LGC two years ago.
The group will be added to LGC’s Health Sciences division, expanding the current range of products available to the pharmaceutical sector. As a result of the terms of the transaction, Quotient and LGC will collaborate as “preferred partners” in the supply of bioanalytical services, at least in the short-term, with the division continuing to operate under the “Quotient” name.
Jeremy Cook, Managing Director of LGC’s Health Sciences, said: “We’re delighted to have acquired Quotient Bioanalytical Sciences, a high quality business which is complementary to our existing activities. We continue to develop our range of first-rate services in the pharmaceutical, biotechnology and agrochemical sectors by offering our customers a unique mix of technical experience, leading edge facilities and knowledgeable people.”
Dr Steve Pleasance, Managing Director of Quotient Bioanalytical Sciences, said: “LGC’s focus on complex analytical chemistry, high quality science and service delivery make them a natural home for our business. Both our organizations have reputations built upon quality and innovation and LGC’s global presence will help support the continued growth of services to our customers.”
For more information: